Suchergebnisse - "Neoadjuvant Therapy / adverse effects"

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Autoren: Uppaluri, Ravindra Haddad, Robert I Tao, Yungan et al.

Quelle: New England Journal of Medicine. 393:37-50

Schlagwörter: Adult, Male, Antibodies, Monoclonal, Humanized / adverse effects, Antibodies, Monoclonal, Humanized / administration & dosage, Young Adult, Chemotherapy, Adjuvant / methods, B7-H1 Antigen / analysis, B7-H1 Antigen / antagonists & inhibitors, Humans, Neoadjuvant Therapy / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Antineoplastic Agents, Immunological / adverse effects, Aged, Aged, 80 and over, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / pathology, Squamous Cell Carcinoma of Head and Neck / pathology, Middle Aged, Head and Neck Neoplasms / drug therapy, Neoadjuvant Therapy / methods, Progression-Free Survival, Squamous Cell Carcinoma of Head and Neck / surgery, Intention to Treat Analysis, B7-H1 Antigen / metabolism, Treatment Outcome, Head and Neck Neoplasms / surgery, Squamous Cell Carcinoma of Head and Neck / drug therapy, Female, Chemotherapy, Adjuvant / adverse effects, Squamous Cell Carcinoma of Head and Neck / mortality

Dateibeschreibung: application/pdf

Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

Autoren: Wouter H Zwart Esmée A Dijkstra Geke A P Hospers et al.

Quelle: BJS Open

Schlagwörter: Postoperative Complications/epidemiology, Male, Perineum, Chemoradiotherapy/adverse effects, Postoperative Complications, Risk Factors, Surgical Wound Dehiscence, Humans, Surgical Wound Infection, Surgical Wound Infection/epidemiology, Aged, Cancer och onkologi, Wound Healing, Proctectomy, Proctectomy/adverse effects, Rectal Neoplasms, Kirurgi, Incidence, Neoadjuvant Therapy/adverse effects, Surgical Wound Dehiscence/epidemiology, Perineum/surgery, Chemoradiotherapy, Middle Aged, Length of Stay, Neoadjuvant Therapy, Length of Stay/statistics & numerical data, Cancer and Oncology, Surgery, Original Article, Female, Rectal Neoplasms/therapy

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40276906
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-556048

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial: a multicentre, randomised, phase 2 trial

Autoren: Knut Jørgen Labori Svein Olav Bratlie Bodil Andersson et al.

Quelle: The Lancet Gastroenterology & Hepatology. 9:205-217

Schlagwörter: Oxaliplatin/therapeutic use, Irinotecan/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoadjuvant Therapy/adverse effects, Carcinoma, Leucovorin, Fluorouracil/adverse effects, Adenocarcinoma, Irinotecan, 16. Peace & justice, Gemcitabine, Leucovorin/adverse effects, Neoadjuvant Therapy, 3. Good health, Pancreatic Neoplasms, Oxaliplatin, Pancreatic Neoplasms/drug therapy, Adenocarcinoma/drug therapy, Pancreatic Ductal/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Humans, Fluorouracil, Capecitabine, Carcinoma, Pancreatic Ductal

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38237621
https://portal.findresearcher.sdu.dk/da/publications/893612f8-7208-4f68-ac90-bc1b6ce3bcb3
https://doi.org/10.1016/S2468-1253(23)00405-3

Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients

Autoren: Mantziari, Styliani Farinha, Hugo Teixeira Messier, Marguerite et al.

Weitere Verfasser: Mantziari, Styliani Farinha, Hugo Teixeira Messier, Marguerite et al.

Quelle: Ann Surg Oncol
Annals of surgical oncology, vol. 31, no. 4, pp. 2499-2508

Schlagwörter: Humans, Esophagectomy, Esophageal Neoplasms/pathology, Carcinoma, Squamous Cell/pathology, Neoadjuvant Therapy/adverse effects, Chemoradiotherapy, Adenocarcinoma/pathology, Retrospective Studies, Treatment Outcome, Esophageal cancer, Neoadjuvant treatment, Pathologic response, Rradiotherapy, Survival, [SDV.CAN] Life Sciences [q-bio]/Cancer, Esophageal Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Thoracic Oncology, Neoadjuvant Therapy, 3. Good health

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38198002
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6E98F3F586ED0
https://serval.unil.ch/resource/serval:BIB_6E98F3F586ED.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_6E98F3F586ED
https://hal.science/hal-04521528v1
https://doi.org/10.1245/s10434-023-14810-8

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

Autoren: Cathomas, Richard Rothschild, Sacha I Hayoz, Stefanie et al.

Quelle: J Clin Oncol

Schlagwörter: Carcinoma, Transitional Cell, Deoxycytidine / adverse effects, Muscles, Medizin, Urinary Bladder Neoplasms / surgery, Urinary Bladder Neoplasms / drug therapy, ORIGINAL REPORTS, Deoxycytidine, Neoadjuvant Therapy, 3. Good health, Urinary Bladder Neoplasms, Cisplatin / adverse effects, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Transitional Cell / surgery, Neoadjuvant Therapy / adverse effects, Humans, Immunotherapy, Cisplatin, Carcinoma, Transitional Cell / drug therapy

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37590894
https://archive-ouverte.unige.ch/unige:175804
https://doi.org/10.1200/jco.23.00363

Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study

Autoren: Florian Pelzer Wilfried Tröger Marcus Reif et al.

Quelle: Breast Cancer

Schlagwörter: Quality of life, Cancer-related fatigue, Breast Neoplasms, Neoadjuvant chemotherapy, Neoadjuvant Therapy, 3. Good health, ddc, Breast cancer, Original Article, Cohort study, Medical and Health Sciences, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Humans, Female [MeSH], Humans [MeSH], Prospective Studies [MeSH], Neoadjuvant Therapy/adverse effects [MeSH], Breast Neoplasms/psychology [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Quality of Life [MeSH], Chemotherapy, Adjuvant/adverse effects [MeSH], Female, Prospective Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37966690
https://repository.publisso.de/resource/frl:6522224
https://mediatum.ub.tum.de/1761322

Sensor based sleep patterns and reported sleep quality in breast cancer patients undergoing neoadjuvant chemotherapy

Autoren: Malveiro, Carla Boavida, Sofia Cargaleiro, Catarina et al.

Weitere Verfasser: Malveiro, Carla Boavida, Sofia Cargaleiro, Catarina et al.

Schlagwörter: Humans, Female, Breast Neoplasms/drug therapy, Neoadjuvant Therapy/adverse effects, Middle Aged, Sleep Quality, Adult, Sleep/drug effects, Aged, Sleep Wake Disorders/etiology, Quality of Life, SDG 3 - Good Health and Well-being

Relation: PURE: 122289512; PubMed: 40646183; PubMedCentral: PMC12254343; Scopus: 105010527059; https://hdl.handle.net/10362/185555

Verfügbarkeit: https://hdl.handle.net/10362/185555
https://doi.org/10.1038/s41598-025-99208-0

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review

Autoren: Eshmuminov, Dilmurodjon Aminjonov, Botirjon Palm, Russell F et al.

Weitere Verfasser: Eshmuminov, Dilmurodjon Aminjonov, Botirjon Palm, Russell F et al.

Quelle: Ann Surg Oncol

Schlagwörter: Leucovorin / therapeutic use, Paclitaxel, 'chemotherapy', 'borderline resectable', 'locally advanced pancreatic cancer', Leucovorin, Pancreatic Tumors, Gemcitabine, Neoadjuvant Therapy, 3. Good health, Pancreatic Neoplasms* / drug therapy, Oxaliplatin, Pancreatic Neoplasms, Pancreatic Neoplasms* / surgery, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Pancreatic Neoplasms* / pathology, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy / adverse effects, Humans, Multicenter Studies as Topic, Fluorouracil, Oxaliplatin / therapeutic use

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37020094

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

Autoren: Emil Christensen Iver Nordentoft Karin Birkenkamp-Demtröder et al.

Quelle: Clin Cancer Res
Christensen, E, Nordentoft, I, Birkenkamp-Demtroder, K, Elbæk, S K, Lindskrog, S V, Taber, A, Andreasen, T G, Strandgaard, T, Knudsen, M, Lamy, P, Agerbæk, M, Jensen, J B & Dyrskjøt, L 2023, 'Cell-free urine-and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer', Clinical Cancer Research, vol. 29, no. 8, pp. 1582–1591. https://doi.org/10.1158/1078-0432.CCR-22-3250

Schlagwörter: Translational Cancer Mechanisms and Therapy, Urinary Bladder Neoplasms/drug therapy, Muscles, Neoadjuvant Therapy/adverse effects, DNA Mutational Analysis, Cystectomy, Neoadjuvant Therapy, 6. Clean water, 3. Good health, Muscles/pathology, Urinary Bladder Neoplasms, Chemotherapy, Adjuvant, Humans, Neoplasm Invasiveness/pathology, Neoplasm Invasiveness, Retrospective Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36780195
https://pure.au.dk/portal/en/publications/fbdb49df-91c2-45a5-98ae-1c5ef2305340
https://pure.au.dk/portal/en/publications/fbdb49df-91c2-45a5-98ae-1c5ef2305340
http://www.scopus.com/inward/record.url?scp=85152599852&partnerID=8YFLogxK
https://pure.au.dk/ws/files/393123549/1582.pdf
https://doi.org/10.1158/1078-0432.CCR-22-3250

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study: An International Multicenter Cohort Study

Autoren: van Veldhuisen, Eran Klompmaker, Sjors Janssen, Quisette P. et al.

Weitere Verfasser: van Veldhuisen, Eran Klompmaker, Sjors Janssen, Quisette P. et al.

Quelle: Ann Surg Oncol
on behalf of the Scientific Committee of the European-African Hepato-Pancreato-Biliary Association 2022, 'Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer : An International Multicenter Cohort Study', Annals of Surgical Oncology. https://doi.org/10.1245/s10434-022-12387-2
ANNALS OF SURGICAL ONCOLOGY

Schlagwörter: Complications, Surgery, anesthesiology, intensive care, radiology, Leucovorin, Folfrinox, BRPC, LAPC, OS, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Pancreatic Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Humans, Retrospective Studies, Kirurgi, Neoadjuvant Therapy/adverse effects, Pancreatic Tumors, Definition, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Classification, Gemcitabine, Neoadjuvant Therapy, 3. Good health, Pancreatic Neoplasms, Fluorouracil/administration & dosage, Leucovorin/administration & dosage, Surgery, Fluorouracil

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36539580
https://research.vumc.nl/en/publications/42c5c893-43e6-4549-919c-beea33f9477b
http://hdl.handle.net/10138/355703
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-237748
https://biblio.ugent.be/publication/01GV5WDX11WX2YGFRBGRAXE46B/file/01GV5WN51S9KR9STR8QV2GFHZD
https://biblio.ugent.be/publication/01GV5WDX11WX2YGFRBGRAXE46B
http://hdl.handle.net/1854/LU-01GV5WDX11WX2YGFRBGRAXE46B
http://doi.org/10.1245/s10434-022-12387-2

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP

Autoren: Jung Hwan Ji Soong June Bae Seul‐Gi Kim et al.

Weitere Verfasser: Jung Hwan Ji Soong June Bae Seul‐Gi Kim et al.

Quelle: Cancer Med
Cancer Medicine, Vol 12, Iss 2, Pp 1409-1417 (2023)

Schlagwörter: Receptor, ErbB-2, Breast Neoplasms, RESEARCH ARTICLES, Carboplatin, Carboplatin / adverse effects, pathologic complete response, 03 medical and health sciences, breast cancer, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy / adverse effects, Humans, RC254-282, Retrospective Studies, anaemia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Trastuzumab, Breast Neoplasms* / complications, Neoadjuvant Therapy, 3. Good health, ErbB-2 / analysis, carboplatin, Female, Breast Neoplasms* / drug therapy, Receptor, Trastuzumab / adverse effects, neoadjuvant chemotherapy

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35837812
https://doaj.org/article/36977867352a46bab6c51ccbc9befe28

Risk factors for pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for non‐small cell lung cancer

Autoren: Ha Eun Kim Woo Sik Yu Chang Young Lee et al.

Weitere Verfasser: Ha Eun Kim Woo Sik Yu Chang Young Lee et al.

Quelle: Thorac Cancer
Thoracic Cancer, Vol 13, Iss 3, Pp 361-368 (2022)

Schlagwörter: Non-Small-Cell Lung* / complications, Male, Lung Neoplasms, Postoperative Complications / etiology, chemoradiotherapy, nomogram, 03 medical and health sciences, non-small cell lung carcinoma, Postoperative Complications, 0302 clinical medicine, Risk Factors, Carcinoma, Non-Small-Cell Lung, Non-Small-Cell Lung* / surgery, Lung Neoplasms* / complications, Neoadjuvant Therapy / adverse effects, Humans, neoadjuvant therapy, RC254-282, Aged, Retrospective Studies, Carcinoma, Lung Neoplasms* / surgery, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Original Articles, Chemoradiotherapy, Middle Aged, non‐small cell lung carcinoma, Neoadjuvant Therapy, 3. Good health, Postoperative Complications / epidemiology, Chemoradiotherapy / adverse effects, Female

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1759-7714.14263
https://pubmed.ncbi.nlm.nih.gov/34905807
https://doaj.org/article/0d9adb4daecc48be81a904ce8f35efbb

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Autoren: Yoon-Koo Kang Jeong Hwan Yook Young-Kyu Park et al.

Weitere Verfasser: Yoon-Koo Kang Jeong Hwan Yook Young-Kyu Park et al.

Quelle: J Clin Oncol

Schlagwörter: Male, 0301 basic medicine, Time Factors, Docetaxel, Adenocarcinoma / pathology, 0302 clinical medicine, Esophagogastric Junction / drug effects, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, Adjuvant, Oxonic Acid / adverse effects, Oxaliplatin / therapeutic use, Tegafur / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Esophagogastric Junction / surgery, ORIGINAL REPORTS, Middle Aged, Neoadjuvant Therapy, Progression-Free Survival, 3. Good health, Oxaliplatin, Drug Combinations, Chemotherapy, Adjuvant, Female, Esophagogastric Junction, Adult, Gastrectomy* / adverse effects, Adenocarcinoma, Adenocarcinoma / mortality, Young Adult, 03 medical and health sciences, Gastrectomy, Stomach Neoplasms, Gastrectomy* / mortality, Republic of Korea, Adenocarcinoma / therapy, Chemotherapy, Humans, Oxaliplatin / adverse effects, Aged, Neoplasm Staging, Esophagogastric Junction / pathology, Neoadjuvant Therapy* / adverse effects, Tegafur / therapeutic use, Docetaxel / adverse effects, Docetaxel / therapeutic use, Oxonic Acid, Oxonic Acid / therapeutic use, Stomach Neoplasms / mortality, Neoadjuvant Therapy* / mortality, Stomach Neoplasms / therapy, Stomach Neoplasms / pathology

Zugangs-URL: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.02914
https://pubmed.ncbi.nlm.nih.gov/34133211
https://europepmc.org/article/MED/34133211
https://www.ncbi.nlm.nih.gov/pubmed/34133211
https://pubmed.ncbi.nlm.nih.gov/34133211/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425847
https://ascopubs.org/doi/10.1200/JCO.20.02914

Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study

Autoren: Hyung-Don Kim Jong Seok Lee Jeong Hwan Yook et al.

Weitere Verfasser: Hyung-Don Kim Jong Seok Lee Jeong Hwan Yook et al.

Quelle: Gastric Cancer. 25:170-179

Schlagwörter: Stomach Neoplasms* / diagnostic imaging, Neoadjuvant Therapy* / adverse effects, Lymph Nodes / pathology, Lymph node staging, Neoadjuvant chemotherapy, Radiological criteria, Neoadjuvant Therapy, 3. Good health, Stomach Neoplasms* / drug therapy, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms* / pathology, Chemotherapy, Adjuvant, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Humans, Lymph Nodes, Gastric cancer, Adjuvant, Neoplasm Staging

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34476643
https://link.springer.com/article/10.1007/s10120-021-01243-z
https://www.ncbi.nlm.nih.gov/pubmed/34476643
https://pubmed.ncbi.nlm.nih.gov/34476643/

Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society

Autoren: Sungmin Park Joon Jeong Wonshik Han et al.

Weitere Verfasser: Sungmin Park Joon Jeong Wonshik Han et al.

Quelle: Breast Cancer. 28:874-883

Schlagwörter: Breast Neoplasms / therapy, Adult, Mammaplasty, Segmental / methods, Breast Neoplasms, Mastectomy, Segmental, Neoadjuvant chemotherapy, Disease-Free Survival, Mammaplasty / adverse effects, Mammaplasty / methods, Neoadjuvant Therapy / statistics & numerical data, 03 medical and health sciences, Neoadjuvant Therapy / adverse effects, Breast cancer, 0302 clinical medicine, Republic of Korea, 80 and over, Humans, Breast reconstruction, Mastectomy, Aged, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Mammaplasty / statistics & numerical data, Breast Neoplasms / mortality, Middle Aged, Prognosis, Combined Modality Therapy, Neoadjuvant Therapy / methods, Neoadjuvant Therapy, 3. Good health, Segmental / adverse effects, Segmental / statistics & numerical data, Female

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33586091
https://link.springer.com/article/10.1007/s12282-021-01223-2
https://europepmc.org/article/MED/33586091
https://www.ncbi.nlm.nih.gov/pubmed/33586091
https://pubmed.ncbi.nlm.nih.gov/33586091/
https://snucm.elsevierpure.com/en/publications/is-mastectomy-with-immediate-reconstruction-safe-for-patients-und
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/52147

Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy

Autoren: Min Kyeong Jang Seho Park Chang Park et al.

Weitere Verfasser: Min Kyeong Jang Seho Park Chang Park et al.

Quelle: Supportive Care in Cancer. 31

Schlagwörter: Sarcopenia, Anemia* / chemically induced OR Anemia* / drug therapy OR Anemia* / epidemiology OR Antineoplastic Combined Chemotherapy Protocols / adverse effects OR Body Composition OR Breast Neoplasms* / drug therapy OR Breast Neoplasms* / etiology OR Female OR Humans OR Neoadjuvant Therapy / adverse effects OR Neutropenia* / chemically induced OR Neutropenia* / drug therapy OR Neutropenia* / epidemiology OR Retrospective Studies OR Sarcopenia* / chemically induced OR Sarcopenia* / epidemiology OR Thrombocytopenia* / drug therapy, Neutropenia, Breast neoplasm, Breast Neoplasms, Anemia, Body composition, Neoadjuvant chemotherapy, Thrombocytopenia, Neoadjuvant Therapy, 3. Good health, Muscle/skeletal, Antineoplastic Combined Chemotherapy Protocols, Body Composition, Humans, Female, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37354335

External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible but Nonrandomized Patients

Autoren: Versteijne, Eva Suker, Mustafa Groen, Jesse V et al.

Quelle: Annals of Surgery. 275:972-978

Schlagwörter: Pancreatic Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Pancreatic Neoplasms/drug therapy, Neoadjuvant Therapy/adverse effects, Antineoplastic Combined Chemotherapy Protocols, Humans, Chemoradiotherapy, 16. Peace & justice, Neoadjuvant Therapy, 3. Good health

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33273349
http://pubmed.ncbi.nlm.nih.gov/33273349/
https://pubmed.ncbi.nlm.nih.gov/33273349/
https://www.ncbi.nlm.nih.gov/pubmed/33273349
https://pure.amsterdamumc.nl/en/publications/1162183b-41b8-49ea-8b38-7f7b3492d0b1
https://doi.org/10.1097/SLA.0000000000004364

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial: Results of the Dutch Randomized Phase III PREOPANC Trial

Autoren: Versteijne, Eva Suker, Mustafa Groothuis, Karin et al.

Quelle: Journal of clinical oncology. 38(16):1763-1773

Schlagwörter: Male, Radiation, Time Factors, Pancreatic Ductal/mortality, Antimetabolites, Carcinoma, Neoadjuvant Therapy/adverse effects, Chemoradiotherapy, Middle Aged, Disease-Free Survival, Neoplasm Recurrence, Local, Antineoplastic/administration & dosage, Pancreatectomy/adverse effects, Disease Progression, Humans, Pancreatic Neoplasms/mortality, Adjuvant/adverse effects, Female, Pancreaticoduodenectomy/adverse effects, Dose Fractionation, Deoxycytidine/administration & dosage, Aged, Netherlands

Zugangs-URL: https://pure.amsterdamumc.nl/en/publications/78dd0138-87ea-46aa-9ac1-fa22b0d2114c

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Autoren: Stahel, R.A. Riesterer, O. Xyrafas, A. et al.

Schlagwörter: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Chemotherapy, Adjuvant, Cisplatin/therapeutic use, Disease Progression, Disease-Free Survival, Europe, Female, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Lung Neoplasms/mortality, Lung Neoplasms/pathology, Lymphatic Metastasis, Male, Mesothelioma/mortality, Mesothelioma/pathology, Middle Aged, Neoadjuvant Therapy/adverse effects, Neoadjuvant Therapy/mortality, Neoplasm Recurrence, Local, Neoplasm Staging, Pemetrexed/therapeutic use, Pleural Neoplasms/mortality, Pleural Neoplasms/pathology, Pneumonectomy/adverse effects, Pneumonectomy/mortality

Relation: The Lancet Oncology; https://iris.unil.ch/handle/iris/153943; serval:BIB_C26272A946F7; 000365803700060

Verfügbarkeit: https://iris.unil.ch/handle/iris/153943
https://doi.org/10.1016/S1470-2045(15)00208-9

Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study: a European multicenter study

Autoren: N Schuring S R Markar E R C Hagens et al.

Quelle: Dis Esophagus
Schuring, N, Markar, S R, Hagens, E R C, Jezerskyte, E, Sprangers, M A G, Lagergren, P, Johar, A, Gisbertz, S S & the LASER study group 2023, 'Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer : a European multicenter study', Diseases of the Esophagus, vol. 36, no. 4, 36. https://doi.org/10.1093/dote/doac069

Schlagwörter: 2. Zero hunger, Esophageal Neoplasms, Neoadjuvant Therapy/adverse effects, Chemoradiotherapy, 16. Peace & justice, Esophageal Neoplasms/surgery, Neoadjuvant Therapy, 3. Good health, Esophagectomy, 03 medical and health sciences, 0302 clinical medicine, Chemotherapy, Adjuvant, Quality of Life, Chemotherapy, Humans, Original Article, Adjuvant

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36241253
https://research.vumc.nl/en/publications/9836d561-e08e-4358-971e-683a03b07942
https://pure.amsterdamumc.nl/en/publications/05e152a9-1164-4cc2-b919-fb7b7be768d5
https://doi.org/10.1093/dote/doac069